Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if his Department will make an assessment of the potential merits of bringing forward legislative proposals on requiring drugs manufacturers to include additional labelling on the front of boxes of medications containing a potentially addictive substance.

The legislative requirements for the labelling of medicines are set out in Schedules 24 and 25 of the Human Medicines Regulations 2012. The regulations are continually under review and updated as and when a need is identified. It should be noted that the current legislative framework already provides for the presentation of ‘any special warning applicable to the product’ on the outer carton of a medicine, which would enable product-specific safety information to be presented on the pack if considered necessary.